Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is the wrong site to post truth about , NWBO’s CEO Linda Powers . Most would rather hang on to slandering lies.
No, a min of $15 B would be hostile bottom number.
I would love to see a hostile takeover
So where is this mythical partner/ buyer agreement with BMY or MRK or anyone for that matter?
I just want to see $10 for my shares and DCVax-L in the daylight being used to help gbm patients live longer or possible have remission.
I would love to see an overseas entity, like a Chinese pharmaceutical company or investing firm , buy NWBO. Especially if they came with a price LP couldn’t resist.
Also, the positive top-line results from its phase 3 trial on DCVax®-L for Glioblastoma give Linda Powers and her board ample bargaining power to sell NWBO’s proprietary vaccine to the highest bidder.
The SEC can with a phone call, gain access to all metadata from the NSA. Yes, it is that easy for them.
It is de risked in UK , but the US FDA is so corrupted with big pharma money , it may never be de risked until the moment we see an approval.
Actually that was 100k shr buy at ask
Success takes time. In a microwave society , patience isn’t a virtue many have acquired or ever appreciated.
This success will change the world of therapy for many cancers as a new platform therapy.
DCVax-L is the most profound advancement in glioblastoma therapy in decades and possibly since the discovery of glioblastoma as a diagnosis. DCVax is a platform therapy making many other therapies more effective and giving more patients a real chance at a normal life with a possibility of complete remission.
Michael Bigger has the tenacity and patience of a saint with NWBO. He has outlasted me on numerous investments and his wait always seems to pay back quite well, while other traders fail to have the ability to weather stock ups and downs.
I’m still in and I have no idea how long NWBO has been in his portfolio,but his tenor and confidence should be good news to longs.
Planet earth is blue and there’s nothing I can do
Another 1.2 million shares sold at a loss by traders so far today
Pathetic to even consider 4 place decimal.
People might want to just send NWBO a check for $40 million so they don’t have to issue more shares. The money to operate needs to come from somewhere
That would be the best , most productive purchase they could ever make , but Merck mgt is too stupid. They try to build equivalent to DCVax with every asinine purchase they make. Maybe a new mgt team at Merck with common sense, would get DCVax , the most incredible advancement in GBM and immunology in history.
The difference between the share price now and the share price when the spoofing crimes were committed , X the fair market value of nwbo should be with what has been considered by most of those aware of the incredible advancement DCVax-L brings to glioblastoma therapy and the patients who will benefit from such an advancement. Then add in the ultimate value of NWBO with approval at all RA which would possibly be around $25b to $50billion right now.
Confirmed what we knew, the SEC only has time to take the small guy to task. The large offenders of ethics and laws , get a pass.
You would understand if she brought a defamation lawsuit against you .
Exactly how much validation beyond the always super validation of JAMA article, is needed? With all the corruption being brought against NWBO stock and the defamatory postings and articles being brought to bear against the shareholders, mgt and company, but no upward movement is happening due to the manipulation itself.
Money means everything to those who wish failure of DCVax-L so they can harvest billions $ to fill their empty lives.
The pain patients and their families endure trying to live through cancer , is immeasurable, but happily ignored by competitors, shorts and even doctors who hang their careers on therapy threatened by DCVax-L
Well put and may the dinner bell ring loud and clear
A minimum of $1 billion would allow for a few hundred million share buy back to reduce share count growth that was issued to pay for development progress in the face of dropping share price. Additional money would help move Direct along in clinical.
Regardless of any other consideration, money to pay all legal and retire all shares no matter what the price climbs through, that were added from the date of first instance of spoofing.
$5 billion would be a good start
Day traders are like scum in a toilet
Well said “ skitahoe”
Wes Christian on Youtube today
Wednesday (Jan 18).
Why don’t you call NWBO and ask them why they don’t have a press conference over every event you deem needing a PR?
Hard to imagine what price NWBO will top off with this constant rise in share price. The ceiling appears to be near $58.00 for right now
Sacrificing lives for personal gain is unconscionable.
Thomas Edison comes to mind. Lots of failures , but learned from each and created a light bulb.
Failures teach more than successes.
Chemo is the equivalent of overpaying to be beaten for your own good with no assurance you will ever heal.
DCVax-L is a more proven biologic than it was 4 months - 15 yrs ago Everyday gets closer to patient and stockholder reward, but it sure gets frustrating seeing such a monumental biologic gbm therapy company stock treated so poorly across the board .
Shorts and traders act as heat sinks to quickly dissipate any perceived heat in nwbo or news.
8 tracks were great and gave many of us entertainment for years. I had one and of course I had an FM converter for my AM car radio before that.
Criminality may be discovered and a prosecutor or AG could easily prefer charges of initiate proceedings.
Down to $.70 from $1.15 in Nov for absolutely no reason. Essentially, a new SOC for gbm selling for change instead of $10+ where it should be at a minimum. To make matters worse, no partner due to incompetence in the big pharma businesses.
So far, no comments from anyone with a clue about anything
In 2014 UK designated DCVax-L as first drug to be considered for early access approval under recently enacted EAMS program at that time .
It would make sense the real world information they had gathered would surpass any info available to any other RA in the world and thereby allowing a faster assessment for approval now.